New eye drops tested for safety in healthy people
Knowledge-focused
Recruiting now
This early-stage study tests the safety and tolerability of BT01001 eye drops in 32 healthy adults aged 18 to 50. Participants receive either the active eye drop or a placebo, and researchers monitor for side effects. The goal is to gather safety information, not to treat any dis…
Phase: PHASE1 • Sponsor: Beyang Therapeutics Co., Ltd. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC